Trial Profile
A Phase II, Multicenter, Randomized, Fasting, Double-Blind, Placebo-Controlled, Safety, Tolerability and Efficacy Study Evaluating a Single Dose of Intravenous NA-1 in Male and Female Patients Undergoing Endovascular Repair of Brain Aneurysms.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2022
Price :
$35
*
At a glance
- Drugs Nerinetide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ENACT
- Sponsors NoNO
- 15 Feb 2022 Results of this post-hoc analysis assessing the association of iatrogenic infarcts with outcomes published in in patients undergoing endovascular repair of intracranial aneurysms the Neurology
- 22 Jul 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 22 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.